| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |